Literature DB >> 3244609

The effect of food on the absorption of controlled-release theophylline in mini-swine.

G K Shiu1, A O Sager, R B Velagapudi, V K Prasad, J P Skelly.   

Abstract

The effect of differing fat contents of food on the bioavailability of theophylline following a 400-mg single dose of Theo-24 was studied in mini-swine. The pharmacokinetics of theophylline, following the intravenous administration of aminophylline equivalent to 5 mg/kg as a single dose, were also studied in the same animals. The terminal plasma half-life of theophylline following an i.v. dose was found to be approximately 24 hr. The volume of distribution, Vdext, and clearance following the i.v. dose were approximately 0.7 liter/kg and 0.023 liter/hr/kg, respectively. The terminal half-life of theophylline following the administration of theophylline capsules under fasting conditions was 21 hr. The average bioavailability under fasting conditions was approximately 80% compared to the i.v. dose. Food appeared to have decreased the rate of absorption but no significant effect on the extent of absorption.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244609     DOI: 10.1023/a:1015815528975

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

2.  Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.

Authors:  M Lagas; J H Jonkman
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.

Authors:  N H Leeds; P Gal; A A Purohit; J B Walter
Journal:  J Clin Pharmacol       Date:  1982-04       Impact factor: 3.126

4.  Delay in the absorption rate of theophylline from a sustained release theophylline preparation caused by food.

Authors:  S Pedersen
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

Review 5.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

6.  Food-induced changes in theophylline absorption from controlled-release formulations. Part II. Importance of meal composition and dosing time relative to meal intake in assessing changes in absorption.

Authors:  A Karim; T Burns; D Janky; A Hurwitz
Journal:  Clin Pharmacol Ther       Date:  1985-12       Impact factor: 6.875

7.  Theophylline QID, TID, BID and now QD? A report on 24-hour dosing with slow-release theophylline formulations with emphasis on analyses of data used to obtain Food and Drug Administration approval for Theo-24.

Authors:  M M Weinberger
Journal:  Pharmacotherapy       Date:  1984 Jul-Aug       Impact factor: 4.705

8.  Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle.

Authors:  A Karim; T Burns; L Wearley; J Streicher; M Palmer
Journal:  Clin Pharmacol Ther       Date:  1985-07       Impact factor: 6.875

9.  Food-induced "dose-dumping" from a once-a-day theophylline product as a cause of theophylline toxicity.

Authors:  L Hendeles; M Weinberger; G Milavetz; M Hill; L Vaughan
Journal:  Chest       Date:  1985-06       Impact factor: 9.410

10.  Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects.

Authors:  M A Osman; R B Patel; D S Irwin; P G Welling
Journal:  Biopharm Drug Dispos       Date:  1983 Jan-Mar       Impact factor: 1.627

View more
  2 in total

1.  The effects of food on the bioavailability of fenofibrate administered orally in healthy volunteers via sustained-release capsule.

Authors:  Hwi-Yeol Yun; Eun Joo Lee; Soo Youn Chung; Sun-Ok Choi; Hyung Kee Kim; Jun-Tack Kwon; Wonku Kang; Kwang-Il Kwon
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  The beagle dog as an animal model for a bioavailability study of controlled-release theophylline under the influence of food.

Authors:  G K Shiu; A LeMarchand; A O Sager; R B Velagapudi; J P Skelly
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.